These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29332383)

  • 1. Developing Pantetheinase-Resistant Pantothenamide Antibacterials: Structural Modification Impacts on PanK Interaction and Mode of Action.
    Barnard L; Mostert KJ; van Otterlo WAL; Strauss E
    ACS Infect Dis; 2018 May; 4(5):736-743. PubMed ID: 29332383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplasmodial Mode of Action of Pantothenamides: Pantothenate Kinase Serves as a Metabolic Activator Not as a Target.
    de Villiers M; Spry C; Macuamule CJ; Barnard L; Wells G; Saliba KJ; Strauss E
    ACS Infect Dis; 2017 Jul; 3(7):527-541. PubMed ID: 28437604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pantothenamides are potent, on-target inhibitors of Plasmodium falciparum growth when serum pantetheinase is inactivated.
    Spry C; Macuamule C; Lin Z; Virga KG; Lee RE; Strauss E; Saliba KJ
    PLoS One; 2013; 8(2):e54974. PubMed ID: 23405100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in pantothenate kinase type determines the pantothenamide mode of action and impacts on coenzyme A salvage biosynthesis.
    de Villiers M; Barnard L; Koekemoer L; Snoep JL; Strauss E
    FEBS J; 2014 Oct; 281(20):4731-53. PubMed ID: 25156889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a Stable and Potent Coenzyme A-Targeting Antiplasmodial Agent: Structure-Activity Relationship Studies of
    Spry C; Barnard L; Kok M; Powell AK; Mahesh D; Tjhin ET; Saliba KJ; Strauss E; de Villiers M
    ACS Infect Dis; 2020 Jul; 6(7):1844-1854. PubMed ID: 32375471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Potent Pantothenamide Inhibitors of Staphylococcus aureus Pantothenate Kinase through a Minimal SAR Study: Inhibition Is Due to Trapping of the Product.
    Hughes SJ; Barnard L; Mottaghi K; Tempel W; Antoshchenko T; Hong BS; Allali-Hassani A; Smil D; Vedadi M; Strauss E; Park HW
    ACS Infect Dis; 2016 Sep; 2(9):627-641. PubMed ID: 27759386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of pantothenamides with vanin inhibitors as a novel antibiotic strategy against gram-positive bacteria.
    Jansen PA; Hermkens PH; Zeeuwen PL; Botman PN; Blaauw RH; Burghout P; van Galen PM; Mouton JW; Rutjes FP; Schalkwijk J
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4794-800. PubMed ID: 23877685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of Klebsiella pneumoniae pantothenate kinase in complex with N-substituted pantothenamides.
    Li B; Tempel W; Smil D; Bolshan Y; Schapira M; Park HW
    Proteins; 2013 Aug; 81(8):1466-72. PubMed ID: 23553820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pantetheinase-resistant pantothenamide with potent, on-target, and selective antiplasmodial activity.
    Macuamule CJ; Tjhin ET; Jana CE; Barnard L; Koekemoer L; de Villiers M; Saliba KJ; Strauss E
    Antimicrob Agents Chemother; 2015; 59(6):3666-8. PubMed ID: 25845876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting the coenzyme A biosynthesis pathway for the identification of new antimalarial agents: the case for pantothenamides.
    Saliba KJ; Spry C
    Biochem Soc Trans; 2014 Aug; 42(4):1087-93. PubMed ID: 25110007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereochemical modification of geminal dialkyl substituents on pantothenamides alters antimicrobial activity.
    Hoegl A; Darabi H; Tran E; Awuah E; Kerdo ES; Habib E; Saliba KJ; Auclair K
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3274-7. PubMed ID: 24986662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geminal dialkyl derivatives of N-substituted pantothenamides: synthesis and antibacterial activity.
    Akinnusi TO; Vong K; Auclair K
    Bioorg Med Chem; 2011 Apr; 19(8):2696-706. PubMed ID: 21440446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyl carrier protein is a cellular target for the antibacterial action of the pantothenamide class of pantothenate antimetabolites.
    Zhang YM; Frank MW; Virga KG; Lee RE; Rock CO; Jackowski S
    J Biol Chem; 2004 Dec; 279(49):50969-75. PubMed ID: 15459190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antimalarial activity of the pantothenamide α-PanAm is via inhibition of pantothenate phosphorylation.
    Chiu JE; Thekkiniath J; Choi JY; Perrin BA; Lawres L; Plummer M; Virji AZ; Abraham A; Toh JY; Zandt MV; Aly ASI; Voelker DR; Mamoun CB
    Sci Rep; 2017 Oct; 7(1):14234. PubMed ID: 29079738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural modification of pantothenamides counteracts degradation by pantetheinase and improves antiplasmodial activity.
    de Villiers M; Macuamule C; Spry C; Hyun YM; Strauss E; Saliba KJ
    ACS Med Chem Lett; 2013 Aug; 4(8):784-9. PubMed ID: 24900746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring structural motifs necessary for substrate binding in the active site of Escherichia coli pantothenate kinase.
    Awuah E; Ma E; Hoegl A; Vong K; Habib E; Auclair K
    Bioorg Med Chem; 2014 Jun; 22(12):3083-90. PubMed ID: 24814884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pantothenate derivatives for anti-malarial chemotherapy.
    Pett HE; Jansen PA; Hermkens PH; Botman PN; Beuckens-Schortinghuis CA; Blaauw RH; Graumans W; van de Vegte-Bolmer M; Koolen KM; Rutjes FP; Dechering KJ; Sauerwein RW; Schalkwijk J
    Malar J; 2015 Apr; 14():169. PubMed ID: 25927675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triazole Substitution of a Labile Amide Bond Stabilizes Pantothenamides and Improves Their Antiplasmodial Potency.
    Howieson VM; Tran E; Hoegl A; Fam HL; Fu J; Sivonen K; Li XX; Auclair K; Saliba KJ
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7146-7152. PubMed ID: 27645235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships and enzyme inhibition of pantothenamide-type pantothenate kinase inhibitors.
    Virga KG; Zhang YM; Leonardi R; Ivey RA; Hevener K; Park HW; Jackowski S; Rock CO; Lee RE
    Bioorg Med Chem; 2006 Feb; 14(4):1007-20. PubMed ID: 16213731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Mechanism of Regulation of Pantothenate Biosynthesis by the PanD-PanZ·AcCoA Complex Reveals an Additional Mode of Action for the Antimetabolite N-Pentyl Pantothenamide (N5-Pan).
    Arnott ZLP; Nozaki S; Monteiro DCF; Morgan HE; Pearson AR; Niki H; Webb ME
    Biochemistry; 2017 Sep; 56(37):4931-4939. PubMed ID: 28832133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.